Sero-prevalence and incidence of A/H1N1 2009 influenza infection in Scotland in winter 2009-2010

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  McLeish, Nigel J ^a   Simmonds, Peter ^a   Robertson, Chris ^b,c   Handel, Ian ^d   McGilchrist, Mark ^e   Singh, Brajendra K ^a   Kerr, Shona ^a   Chase Topping, Margo E ^a   Sinka, Katy ^c   Bronsvoort, Mark ^d   Porteous, David J ^a   Carman, William ^f   McMenamin, James ^c   Leigh Brown, Andrew ^a   Woolhouse, Mark E J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c HEALTH PROTECTION SCOTLAND   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGE; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS REACTION; FEMALE; HEALTH CARE PLANNING; HUMAN; INCIDENCE; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; PUBLIC HEALTH SERVICE; SEROCONVERSION; SERODIAGNOSIS; SEROPREVALENCE; TIME; UNITED KINGDOM; WINTER; ADOLESCENT; EPIDEMIOLOGY; IMMUNOLOGY; INFLUENZA; MIDDLE AGED; PATHOGENICITY; SEASON; VACCINATION;

ADOLESCENT; ADULT; AGED; CROSS REACTIONS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SCOTLAND; SEASONS; SEROEPIDEMIOLOGIC STUDIES; VACCINATION; YOUNG ADULT;

EID: 79958099808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020358     Document Type: Article

References (21)

1. Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM, (2009) Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med 361: 112-115.
2. Van Kerkhove MD, Asikainen T, Becker NG, Bjorge S, Desenclos JC, et al. (2010) Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med 7: e1000275.
3. World Health Organisation (2010) pp. 229-235 Seroepidemiological studies of pandemic influenza A (H1N1) 2009 virus.
4. Scotland HP, (2010) The Pandemic of Influenza A(H1N1) Infection in Scotland 2009-2010: Report on the Health Protection Response. Glasgow.
5. Baguelin M, Hoschler K, Stanford E, Waight P, Hardelid P, et al. (2011) Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation. PLoS One 6: e17074.
6. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 375: 1100-1108.
7. Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, et al. (2011) Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009. Health Technol Assess 14: 115-192.
8. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. (2010) Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic. PLoS One 5: e13211.
9. Adamson WE, Maddi S, Robertson C, McDonagh S, Molyneaux PJ, et al. (2010) 2009 pandemic influenza A(H1N1) virus in Scotland: geographically variable immunity in Spring 2010, following the winter outbreak. Euro Surveill 15.
10. Smith BH, Campbell H, Blackwood D, Connell J, Connor M, et al. (2006) Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability. BMC Med Genet 7: 74.
11. Nicholson KG, Colegate AE, Podda A, Stephenson I, Wood J, et al. (2001) Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 357: 1937-1943.
12. Papenburg J, Baz M, Hamelin ME, Rheaume C, Carbonneau J, et al. (2011) Evaluation of Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus. Clin Vaccine Immunol 18: 520-522.
13. Team RDCR: A Language and Environment for Statistical Computing (2007) Vienna, Austria. R Foundation for Statistical Computing.
14. Kissling E, Valenciano M, Falcao J, Larrauri A, Widgren K, et al. (2009) "I-MOVE" towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008-9. Euro Surveill 14.
15. Plummer M, JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling (2003) pp. 1-10 Vienna, Austria.
16. Brooks SP, Gelman A, (1998) General Methods for Monitoring Convergence of Iterative Simulations. Journal of Computational and Graphical Statistics 7: 434-455.
17. Chen MI, Barr IG, Koh GC, Lee VJ, Lee CP, et al. (2010) Serological response in RT-PCR confirmed H1N1-2009 influenza a by hemagglutination inhibition and virus neutralization assays: an observational study. PLoS One 5: e12474.
18. Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, et al. (2010) Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One 5: e11601.
19. Waalen K, Kilander A, Dudman SG, Krogh GH, Aune T, et al. (2010) High prevalence of antibodies to the 2009 pandemic influenza A(H1N1) virus in the Norwegian population following a major epidemic and a large vaccination campaign in autumn 2009. Euro Surveill 15.
20. Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J, (2010) Vaccine effectiveness in pandemic influenza- primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine. Health Technol Assess 14: 313-346.
21. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, et al. (2010) Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One 5: e12562.